Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 114,369 | 39,615 | 202,129 | 144,427 | 82,793 |
| Depreciation Amortization | 42,395 | 21,375 | 58,586 | 49,519 | 16,206 |
| Income taxes - deferred | 15,381 | 3,874 | 40,005 | 25,329 | -372 |
| Accounts receivable | -15,307 | 36,189 | -83,941 | -76,186 | -32,252 |
| Other Working Capital | -37,065 | 13,814 | -88,445 | -82,445 | -22,395 |
| Other Operating Activity | 34,033 | -27,903 | 111,776 | 97,013 | 44,042 |
| Operating Cash Flow | $153,806 | $86,964 | $240,110 | $157,657 | $88,022 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,586 | -48,785 | 490,919 | 500,306 | 500,306 |
| PPE Investments | -9,754 | -11,377 | 21,196 | 13,555 | 14,563 |
| Net Acquisitions | N/A | N/A | -999,120 | -999,120 | -999,120 |
| Investing Cash Flow | $-5,168 | $-60,162 | $-487,005 | $-485,259 | $-484,251 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 1,072,000 | 1,072,000 | 370,000 |
| Debt Repayment | -13,483 | -13,483 | -516,573 | -516,573 | N/A |
| Common Stock Issued | 1,398 | N/A | 14,050 | 7,081 | 4,445 |
| Common Stock Repurchased | -150,083 | -150,083 | -200,002 | -200,001 | N/A |
| Other Financing Activity | 0 | -1,048 | -7,104 | -6,465 | -6,003 |
| Financing Cash Flow | $-162,168 | $-164,614 | $362,371 | $356,042 | $368,442 |
| Beginning Cash Position | 234,695 | 234,695 | 119,219 | 119,219 | 119,219 |
| End Cash Position | 221,165 | 96,883 | 234,695 | 147,659 | 91,432 |
| Net Cash Flow | $-13,530 | $-137,812 | $115,476 | $28,440 | $-27,787 |
| Free Cash Flow | |||||
| Operating Cash Flow | 153,806 | 86,964 | 240,110 | 157,657 | 88,022 |
| Capital Expenditure | -9,754 | -11,377 | -4,810 | -2,466 | -1,458 |
| Free Cash Flow | 144,052 | 75,587 | 235,300 | 155,191 | 86,564 |